Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Common variable immune deficiency and autoimmunity.

Daniel Brandt1, M Eric Gershwin

  • 1Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, 451 E. Health Sciences Drive, Suite 6510, Davis, CA 95616, USA.

Autoimmunity Reviews
|August 22, 2006
PubMed
Summary

Common variable immunodeficiency (CVID) increases autoimmunity risk due to immune dysregulation and genetic factors. Treatment often involves IVIG and corticosteroids, but the exact causes of autoimmunity in CVID are still being researched.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Senescent Fibroblasts Drive Melanoma Progression Through GCP-2 Induced CREB Phosphorylation Enhancing Glycolysis.

Aging cell·2025
Same author

Spatial proteomics in three-dimensional intact specimens.

Cell·2022
Same author

Functional and metabolic fitness of human CD4<sup>+</sup> T lymphocytes during metabolic stress.

Life science alliance·2021
Same author

Author Correction: Endogenous FGF21-signaling controls paradoxical obesity resistance of UCP1-deficient mice.

Nature communications·2021
Same author

Heavy Metals Exposure and Alzheimer's Disease and Related Dementias.

Journal of Alzheimer's disease : JAD·2020
Same author

Endogenous FGF21-signaling controls paradoxical obesity resistance of UCP1-deficient mice.

Nature communications·2020

Area of Science:

  • Immunology
  • Genetics
  • Internal Medicine

Background:

  • Common variable immunodeficiency (CVID) is a complex syndrome marked by hypogammaglobulinemia.
  • Autoimmunity, including autoimmune cytopenias, sarcoidosis-like conditions, and inflammatory bowel disease, is frequently observed in CVID patients.
  • Recent research highlights specific immune defects and genetic links in CVID, suggesting a heightened susceptibility to self-antigen recognition.

Purpose of the Study:

  • To explore the immunological defects and genetic associations contributing to autoimmunity in CVID.
  • To understand the underlying mechanisms driving the increased incidence of autoimmune disorders in individuals with CVID.
  • To review current treatment strategies for autoimmune manifestations in CVID.

Main Methods:

Related Experiment Videos

  • Characterization of selective immunological defects in CVID patients.
  • Analysis of genetic predispositions associated with CVID and autoimmunity.
  • Review of existing literature on treatment modalities for autoimmune complications in CVID.

    • Main Results:

    • CVID is associated with a significant tendency towards loss of immune tolerance.
    • Specific genetic factors and immune dysregulation are implicated in the development of autoimmunity.
    • Current treatments include high-dose intravenous immunoglobulin (IVIG) and corticosteroids, with other therapies like TNF-alpha antagonists also noted.

    Conclusions:

    • The precise etiology of heightened autoimmunity in CVID remains unclear.
    • A combination of genetic susceptibility, environmental triggers (like antigen exposure), and inherent immune dysregulation likely contributes to autoimmunity in CVID.
    • Further research is needed to fully elucidate the mechanisms and optimize management strategies for autoimmune conditions in CVID.